BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
  • Homepage
  • Online Submission
Number of total visits
297634
Number of visits today
13
Number of downloads
79587
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Talmon M, Massara E, Brunini C, Fresu LG. Comparison of anti-inflammatory mechanisms between doxofylline and theophylline in human monocytes. Pulm Pharmacol Ther 2019;59:101851. [PMID: 31563516 DOI: 10.1016/j.pupt.2019.101851] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Jing N, Liu X, Jin M, Yang X, Hu X, Li C, Zhao K. Fubrick tea attenuates high-fat diet induced fat deposition and metabolic disorder by regulating gut microbiota and caffeine metabolism. Food Funct 2020;11:6971-86. [PMID: 32697259 DOI: 10.1039/d0fo01282c] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
2 Haj Ahmed W, Peiro C, Fontaine J, Ryan BJ, Kinsella GK, O'Sullivan J, Grolleau JL, Henehan GTM, Carpéné C. Methylxanthines Inhibit Primary Amine Oxidase and Monoamine Oxidase Activities of Human Adipose Tissue. Medicines (Basel) 2020;7:E18. [PMID: 32252407 DOI: 10.3390/medicines7040018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Cazzola M, Matera MG. The effect of doxofylline in asthma and COPD. Respir Med 2020;164:105904. [PMID: 32094104 DOI: 10.1016/j.rmed.2020.105904] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Calzetta L, Matera MG, Goldstein MF, Fairweather WR, Howard WW, Cazzola M, Rogliani P. A long-term clinical trial on the efficacy and safety profile of doxofylline in Asthma: The LESDA study. Pulm Pharmacol Ther 2020;60:101883. [PMID: 31884206 DOI: 10.1016/j.pupt.2019.101883] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345